NASDAQ : AGIO
Agios Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 30.55 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.82B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Agios Pharmaceuticals, Inc. (AGIO) reported revenue of 98.34M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 98.34M | 54.03M | 36.50M | 26.82M | 14.24M | |
| Cost of Revenue | 364.63M | 345.88M | 305.45M | 298.41M | 281.61M | 256.97M |
| Gross Profit | -266.29M | -291.85M | -268.95M | -271.58M | -267.37M | -256.97M |
| Selling, General & Admin | 192.74M | 180.28M | 156.78M | 119.90M | 121.67M | 121.44M |
| Operating Expenses | 192.74M | 180.28M | 156.78M | 119.90M | 121.67M | 121.44M |
| Operating Income | -459.02M | -472.13M | -425.74M | -391.49M | -389.05M | -378.42M |
| Interest & Investment Income | 46.30M | 56.38M | 48.08M | 33.34M | 12.79M | 836.00K |
| Other Non Operating Income (Expenses) | 418.00K | 1.96M | 6.49M | 6.05M | 16.60M | 21.07M |
| EBT Excluding Unusual Items | -412.30M | -413.80M | -371.17M | -352.09M | -359.65M | -356.51M |
| Gain (Loss) on Sale of Assets | 200.00M | |||||
| Other Unusual Items | 889.14M | 127.85M | ||||
| Pretax Income | -412.30M | -413.80M | 717.97M | -352.09M | -231.80M | -356.51M |
| Income Tax Expense | -1.02M | -1.02M | 44.24M | |||
| Earnings From Continuing Operations | -411.29M | -412.78M | 673.73M | -352.09M | -231.80M | -356.51M |
| Earnings From Discontinued Operations | 1.96B | |||||
| Net Income | -411.29M | -412.78M | 673.73M | -352.09M | -231.80M | 1.60B |
| Net Income to Common | -411.29M | -412.78M | 673.73M | -352.09M | -231.80M | 1.60B |
| Shares Outstanding (Basic) | 58.69M | 57.97M | 56.81M | 55.65M | 54.79M | 60.45M |
| Shares Outstanding (Diluted) | 58.69M | 57.97M | 57.89M | 55.65M | 54.79M | 60.45M |
| EPS (Basic) | -7.01 | -7.12 | 11.86 | -6.33 | -4.23 | 26.55 |
| EPS (Diluted) | -7.01 | -7.12 | 11.64 | -6.33 | -4.23 | 26.55 |
| Free Cash Flow | -365.25M | -377.29M | -391.53M | -297.06M | -314.36M | -413.06M |
| Free Cash Flow Per Share | -6.22 | -6.51 | -6.76 | -5.34 | -5.74 | -6.83 |
| Gross Margin | -270.79% | |||||
| Operating Margin | -466.78% | -873.87% | -1,166.47% | -1,459.52% | -2,732.07% | |
| Profit Margin | -418.24% | -764.01% | 1,845.92% | -1,312.63% | -1,627.82% | |
| Free Cash Flow Margin | -371.42% | -698.33% | -1,072.73% | -1,107.49% | -2,207.58% | |
| EBITDA | -453.67M | -466.95M | -420.08M | -384.86M | -380.48M | -369.18M |
| D&A For EBITDA | 5.35M | 5.18M | 5.65M | 6.62M | 8.56M | 9.24M |
| EBIT | -459.02M | -472.13M | -425.74M | -391.49M | -389.05M | -378.42M |
| Effective Tax Rate | 6.16% | |||||
| Revenue as Reported | 98.34M | 54.03M | 36.50M | 26.82M | 14.24M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 99.65M | 89.13M | 76.25M | 88.20M | 139.26M | 203.13M |
| Short-Term Investments | 517.93M | 765.29M | 817.46M | 688.72M | 643.86M | 816.89M |
| Cash & Short-Term Investments | 617.58M | 854.42M | 893.71M | 776.93M | 783.12M | 1.02B |
| Accounts Receivable | 24.22M | 10.58M | 4.11M | 2.81M | 2.21M | |
| Other Receivables | 200.00K | 1.10M | 300.00K | 7.28M | ||
| Receivables | 24.22M | 10.78M | 4.11M | 3.91M | 2.51M | 7.28M |
| Inventory | 30.15M | 32.92M | 27.62M | 19.08M | 8.49M | |
| Prepaid Expenses | 45.72M | 43.93M | 40.16M | 33.92M | 38.66M | 36.94M |
| Total Current Assets | 717.67M | 942.05M | 965.60M | 833.84M | 832.77M | 1.06B |
| Property, Plant & Equipment | 33.82M | 41.23M | 54.55M | 69.79M | 88.12M | 104.23M |
| Long-Term Investments | 347.25M | 310.01M | 638.32M | 29.43M | 313.87M | 266.38M |
| Other Long-Term Assets | 9.68M | 3.93M | 4.72M | 4.06M | 3.96M | 2.90M |
| Total Assets | 1.11B | 1.30B | 1.66B | 937.12M | 1.24B | 1.44B |
| Accounts Payable | 16.34M | 18.36M | 16.64M | 9.78M | 18.62M | 16.70M |
| Accrued Expenses | 34.65M | 45.46M | 46.86M | 43.17M | 30.35M | 31.97M |
| Current Portion of Leases | 19.23M | 18.39M | 16.78M | 15.01M | 13.66M | 11.16M |
| Current Income Taxes Payable | 871.00K | |||||
| Total Current Liabilities | 70.22M | 82.21M | 81.16M | 67.95M | 62.63M | 59.83M |
| Long-Term Leases | 11.95M | 21.82M | 40.21M | 56.99M | 72.00M | 85.94M |
| Other Long-Term Liabilities | 240.00K | 90.00K | 880.00K | 1.16M | 3.28M | |
| Total Liabilities | 82.40M | 104.11M | 122.24M | 126.10M | 137.90M | 145.76M |
| Common Stock | 76.00K | 75.00K | 73.00K | 72.00K | 71.00K | 71.00K |
| Additional Paid-In Capital | 2.59B | 2.56B | 2.49B | 2.44B | 2.39B | 2.33B |
| Retained Earnings | -761.52M | -561.71M | -148.92M | -822.65M | -470.56M | -238.76M |
| Treasury Stock | -802.49M | -802.49M | -802.49M | -802.49M | -802.49M | -802.49M |
| Comprehensive Income & Other | -1.79M | 2.19M | -1.52M | -441.00K | -12.54M | -1.20M |
| Shareholders' Equity | 1.03B | 1.19B | 1.54B | 811.02M | 1.10B | 1.29B |
| Total Liabilities & Equity | 1.11B | 1.30B | 1.66B | 937.12M | 1.24B | 1.44B |
| Total Debt | 31.17M | 40.21M | 56.99M | 72.00M | 85.66M | 97.09M |
| Net Cash (Debt) | 933.66M | 1.12B | 1.48B | 734.37M | 1.01B | 1.19B |
| Net Cash Per Share | 15.91 | 19.39 | 25.48 | 13.20 | 18.46 | 19.67 |
| Filing Date Shares Outstanding | 59.70M | 58.59M | 57.30M | 56.19M | 55.29M | 54.64M |
| Total Common Shares Outstanding | 59.60M | 58.45M | 57.16M | 55.95M | 55.04M | 54.33M |
| Working Capital | 647.45M | 859.85M | 884.44M | 765.88M | 770.14M | 1.00B |
| Book Value Per Share | 17.21 | 20.41 | 26.96 | 14.50 | 20.00 | 23.78 |
| Tangible Book Value | 1.03B | 1.19B | 1.54B | 811.02M | 1.10B | 1.29B |
| Tangible Book Value Per Share | 17.21 | 20.41 | 26.96 | 14.50 | 20.00 | 23.78 |
| Machinery | 30.62M | 29.76M | 29.73M | 35.12M | 33.80M | |
| Construction In Progress | 2.75M | 897.00K | 608.00K | 657.00K | 7.37M | |
| Leasehold Improvements | 37.52M | 37.52M | 37.28M | 37.28M | 32.73M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -411.29M | -412.78M | 673.73M | -352.09M | -231.80M | 1.60B |
| Depreciation & Amortization | 5.35M | 5.18M | 5.65M | 6.62M | 8.56M | 9.24M |
| Loss (Gain) From Sale of Assets | 5.00K | -200.04M | 553.00K | -48.00K | 12.00K | |
| Loss (Gain) From Sale of Investments | -5.91M | -7.31M | -14.65M | -5.08M | -1.20M | 6.95M |
| Stock-Based Compensation | 57.98M | 52.55M | 42.85M | 44.77M | 49.30M | 53.51M |
| Other Operating Activities | 37.91M | 22.43M | -877.61M | 28.22M | -117.86M | -1.95B |
| Change in Accounts Receivable | -19.23M | -6.47M | -1.30M | -604.00K | -2.21M | |
| Change in Inventory | 696.00K | -5.30M | -8.54M | -10.58M | -8.49M | |
| Change in Accounts Payable | -1.25M | 1.75M | 6.60M | -8.73M | 3.44M | 1.86M |
| Change in Income Taxes | -871.00K | 871.00K | ||||
| Change in Other Net Operating Assets | -24.86M | -22.14M | -17.40M | 864.00K | -9.17M | -38.69M |
| Operating Cash Flow | -360.60M | -372.98M | -389.84M | -296.06M | -309.48M | -407.32M |
| Capital Expenditures | -4.66M | -4.32M | -1.69M | -999.00K | -4.88M | -5.74M |
| Sale of Property, Plant & Equipment | 40.00K | 1.32M | 964.00K | |||
| Divestitures | 200.00M | |||||
| Sale (Purchase) of Intangibles | -25.00M | -10.00M | -17.50M | |||
| Investment in Securities | 396.81M | 391.50M | -724.05M | 256.75M | 115.39M | -548.42M |
| Other Investing Activities | 889.14M | 131.78M | 1.80B | |||
| Investing Cash Flow | 367.15M | 377.18M | 363.44M | 239.57M | 243.26M | 1.25B |
| Long-Term Debt Repaid | -331.00K | -578.00K | ||||
| Net Debt Issued (Repaid) | -331.00K | -578.00K | ||||
| Issuance of Common Stock | 12.22M | 8.68M | 14.44M | 5.43M | 2.68M | 37.30M |
| Repurchase of Common Stock | -802.49M | |||||
| Financing Cash Flow | 12.22M | 8.68M | 14.44M | 5.43M | 2.35M | -765.77M |
| Net Cash Flow | 18.78M | 12.88M | -11.96M | -51.05M | -63.87M | 75.69M |
| Free Cash Flow | -365.25M | -377.29M | -391.53M | -297.06M | -314.36M | -413.06M |
| Free Cash Flow Margin | -371.42% | -698.33% | -1,072.73% | -1,107.49% | -2,207.58% | |
| Free Cash Flow Per Share | -6.22 | -6.51 | -6.76 | -5.34 | -5.74 | -6.83 |
| Levered Free Cash Flow | -274.60M | -267.97M | -222.83M | -215.06M | -195.32M | -198.29M |
| Unlevered Free Cash Flow | -274.60M | -267.97M | -222.83M | -215.06M | -195.32M | -198.29M |
| Cash Income Tax Paid | 628.00K | 43.15M | 1.57M | 16.08M | ||
| Change in Working Capital | -44.65M | -33.04M | -19.77M | -19.06M | -16.43M | -36.82M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.82B | 1.59B | 1.87B | 1.24B | 1.54B | 1.79B |
| Enterprise Value | 890.23M | 374.62M | 274.20M | 447.81M | 606.80M | 488.06M |
| Last Close Price | 30.55 | 27.22 | 32.86 | 22.27 | 28.08 | 32.87 |
| PE Ratio | 2.78 | 1.11 | ||||
| Forward PE | 7.84 | 7.84 | ||||
| PS Ratio | 18.55 | 29.38 | 51.35 | 46.40 | 108.35 | |
| PB Ratio | 1.77 | 1.33 | 1.22 | 1.53 | 1.40 | 1.38 |
| P/TBV Ratio | 1.78 | 1.33 | 1.22 | 1.53 | 1.40 | 1.38 |
| EV/Sales Ratio | 9.05 | 6.93 | 7.51 | 16.70 | 42.61 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.09 | 0.08 | 0.07 |
| Net Debt / Equity Ratio | -0.91 | -0.94 | -0.96 | -0.91 | -0.92 | -0.92 |
| Net Debt / EBITDA Ratio | 2.06 | 2.41 | 3.51 | 1.91 | 2.66 | 3.22 |
| Net Debt / FCF Ratio | 2.56 | 2.98 | 3.77 | 2.47 | 3.22 | 2.88 |
| Asset Turnover | 0.08 | 0.04 | 0.03 | 0.03 | 0.01 | |
| Inventory Turnover | 11.96 | 11.43 | 13.08 | 21.65 | ||
| Quick Ratio | 9.14 | 10.53 | 11.06 | 11.49 | 12.54 | 17.17 |
| Current Ratio | 10.22 | 11.46 | 11.90 | 12.27 | 13.30 | 17.79 |
| Return on Equity (ROE) | -34.34% | -30.20% | 57.29% | -36.83% | -19.38% | -42.15% |
| Return on Assets (ROA) | -22.24% | -19.93% | -20.47% | -22.49% | -18.17% | -20.65% |
| Return on Invested Capital (ROIC) | -108.33% | -87.18% | -98.60% | -153.69% | -100.74% | -102.54% |
| Return on Capital Employed (ROCE) | -44.20% | -38.90% | -26.90% | -45.00% | -33.10% | -27.50% |
| Earnings Yield | -22.94% | -26.00% | 35.95% | -28.29% | -15.02% | 89.89% |
| FCF Yield | -20.03% | -23.77% | -20.89% | -23.87% | -20.38% | -23.14% |
| Buyback Yield / Dilution | -0.43% | -0.14% | -4.02% | -1.57% | 9.36% | 12.39% |